T

Tarveda Therapeutics

31 employees

Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Diagnostics
Health Care
Therapeutics
Medical

Date founded

2011

Funding rounds raised

Total raised

$38M

from 12 investors over 12 rounds

T

Tarveda Therapeutics raised $30M on February 2, 2017

Investors: Versant Ventures, +ND Capital, Flagship Ventures and Novo Holdings

T

Tarveda Therapeutics raised $38M on January 27, 2016

Investors: Novo Holdings

T

Tarveda Therapeutics raised $21M on January 7, 2015

Investors: Handshake Ventures, Flagship Ventures and +ND Capital

T

Tarveda Therapeutics raised $21M on December 24, 2013

Investors: +ND Capital and Flagship Ventures

T

Tarveda Therapeutics raised $2.8M on January 6, 2012

Investors: Flagship Ventures and +ND Capital

FAQ